Phillips-Medisize Wins “Best Connected Health Platform” Designation in 2019 MedTech Breakthrough Awards Program
HUDSON, Wis.–(BUSINESS WIRE)–Phillips-Medisize,
a Molex company, today announced that MedTech
Breakthrough, an independent organization that recognizes the top
companies and solutions in the global health and medical technology
market, has selected its Connected Health Platform (CHP) as the winner
of its “Best Overall Connected Healthcare Solution” award in the 2019
MedTech Breakthrough Awards program.
Incorporating more than a decade of experience in developing connected
health solutions, the Phillips-Medisize CHP encompasses extensive
information-sharing, analytics capabilities, robust cybersecurity and
streamlined regulatory documentation to support medical device,
pharmaceutical and diagnostics companies.
“We extend a hearty congratulations to the Phillips-Medisize team on
their success and innovation in the connected health space and are proud
to recognize them as a marquee 2019 MedTech Breakthrough Award winner,”
said James Johnson, managing director, MedTech Breakthrough. “Their
cloud-based CHP helps pharmaceutical companies and drug delivery device
developers tackle the worldwide challenge of patient medication
adherence, while speeding development time to market and keeping
healthcare costs down.”
The mission of the MedTech Breakthrough Awards is to honor excellence
and recognize the innovation, hard work and success in a range of health
and medical technology categories, including Robotics, Clinical
Administration, Telehealth, Patient Engagement, Electronic Health
Records (EHR), mHealth, Medical Devices, Medical Data and many more.
This year’s program attracted more than 3,500 nominations from over 15
different countries throughout the world.
“We thank the MedTech Breakthrough organization for taking the time and
effort to acknowledge Phillips-Medisize for our CHP solution,” said Matt
Jennings, CEO and President of Phillips-Medisize. “We’re honored to
receive this award as a testament that our global team of experts
continues to deliver innovative ideas to help transform the diagnosis
and delivery of healthcare.”
The award-winning Connected Health Platform (CHP) is registered with the
FDA as a Medical Device Data System (MDDS) and is designed from the
ground up to support patients with their medication regimes and related
data. The system includes simple, intuitive mobile apps and reminders to
support and motivate users.
Phillips-Medisize’s CHP can track medication usage for multiple drug
products, on a global basis, in real-time. The CHP comes with a Software
Development Toolkit (SDK) and defined, extensible API, allowing any
device to be connected to the system. This enables pharmaceutical
companies to deploy a single solution across all therapy areas and drug
compounds if desired, instead of having to utilize different companies’
platforms for each product and device type.
Pharmaceutical companies and payer/provider organizations also benefit
from the platform’s powerful analytics package, which is designed to
connect and display information from connected drug delivery devices,
biosensors and regulated Mobile Medical Applications (SaMD/MMA). This
enables customers to quickly generate views of their data and create
data presentation layers for use by the analytics engine, providing deep
insight into how medication is taken.
Additionally, with the Phillips-Medisize CHP being built on
InterSystem’s HealthShare technology, the solution benefits from the
interoperability ingrained within this technology. This allows the CHP
to integrate healthcare data from multiple sources via its enterprise
master patient index. The data can be made actionable for payers and
providers, allowing connection, via integration, to various EMR and EHR
systems.
MD&M East attendees have the opportunity to see the CHP and other
Phillips-Medisize medical device solutions at Booth 1615 at the Jacob K.
Javits Convention Center in New York, New York – June 11 – 13, 2019.
About Phillips-Medisize:
Phillips-Medisize, a Molex company, is an end-to-end provider of
innovation, development and manufacturing solutions to the
pharmaceutical, diagnostics, medical device and specialty commercial
market segments. Backed by the combined global resources of Molex and
its parent company Koch Industries, Phillips-Medisize’s core advantage
is the knowledge of its people to integrate design, molding,
electronics, and automation, providing innovative, high-quality
manufacturing solutions. For more information, please visit www.phillipsmedisize.com or www.molex.com.
About MedTech Breakthrough:
Part of Tech
Breakthrough, a leading market intelligence and recognition platform
for global technology innovation and leadership, the MedTech
Breakthrough Awards program is an independent program devoted to
honoring excellence in medical and health related technology companies,
products, services and people. The MedTech Breakthrough Awards provide a
platform for public recognition around the achievements of breakthrough
health and medical companies and products in categories that include
Patient Engagement, mHealth, Health & Fitness, Clinical Administration,
Healthcare IoT, Medical Data, Healthcare Cybersecurity and more. For
more information visit MedTechBreakthrough.com.
Contacts
For more information, contact:
Heather Ditzler
Phone +1
715-377-7261
heather.ditzler@phillipsmedisize.com
Christina
Johnson
Phone +1 715-748-8928
christina.johnson@phillipsmedisize.com
Paula
Kasper (Europe)
Phone +41448383933
paula.kasper@phillipsmedisize.com
